The growth-promoting effect of growth hormone (GH) is primarily mediated by insulin-like growth factor-1 (IGF-1). The liver is the main source of circulating IGF-I. The authors have used rodent primary hepatocytes for studies on pharmacological intervention of IGF-I mRNA expression. A 96-well nonradioactive IGF-1 mRNA quantification assay was developed, based on the hybridization of sense and antisense RNA probes, to replicate membranes with crude hepatocyte lysates. The sense hybridization was used as an internal standard. The antagonistic properties of a set of GH-receptor binding compounds were evaluated. Two compounds were found to down-regulate IGF-I mRNA. Effects due to metabolic inhibition or toxicity were excluded using a cell proliferation assay. To investigate potential unspecific transcriptional effects, the mRNA levels of the housekeeping genes, β-actin and glyceraldehyde-3-phosphate dehydrogenase (GAPDH), were determined. Two other GH-regulated genes, cytochrome P450 2C12 (CYP2C12) and a rat homologue to the human α1B-glycoprotein (A1BG), were quantified by RNase protection assays and found to be down-regulated, confirming the antagonistic property of 1 compound. In conclusion, a direct filter hybridization assay of hepatocyte lysates using nonradioactive sense and antisense probes can be used for quantitative mRNA measurements and could constitute a valuable tool in screening for pharmacologically active compounds. (Journal of Biomolecular Screening 2005:260-269) 
INTRODUCTION
G ROWTH HORMONE (GH) STIMULATES LONGITUDINAL BONE GROWTH, and the primary mediator of this effect is insulinlike growth factor-1 (IGF-1). 1 IGF-1 production in bone and muscle mediates local paracrine and autocrine effects, whereas the main circulating pool of IGF-1 is produced in the liver. 2, 3 Thus, the liver constitutes a valuable target organ for studies on GH-induced IGF-1 production. GH-responsive cell lines that express the IGF-I gene have been difficult to find, 4 whereas cultured primary hepatocytes have been shown to maintain their GH responsiveness and to express IGF-1 mRNA in response to the hormone. 5 Changes in gene expression levels are important markers of biological activity of drugs and chemical compounds. Methods to quantify specific mRNA levels in cells or tissues usually require isolation and purification of RNA, additional cDNA synthesis, and the use of special equipment or radioactively labeled probes. 6, 7 When determining dose-response relationships or screening compound libraries, a large number of data points are needed, and monolayers of cells or tissue slices are preferably analyzed in microplates. It is of interest to develop and optimize minimally laborious and nonradioactive methods for mRNA quantification that are compatible with the standard microplate format.
This aims of this study were 1) to set up a nonradioactive mRNA quantitation assay for determining IGF-1 expression in cultured primary hepatocytes, 2) to correlate the determined mRNA levels to an adequate internal standard, and 3) to use this assay for investigation of the IGF-1 mRNA response to human GH (hGH) and potential hGH antagonists. Previous studies have shown that the RNA purification step can be circumvented by direct molecular hybridization of unfractionated cells solubilized in guanidine thiocyanate (GuSCN), 8 and we adopted this strategy. In all quantitative mRNA assays, it is necessary to correlate the deter-mined mRNA expression level to an internal standard, thereby eliminating experimental variations such as different amounts of starting material. However, commonly used standards such as the housekeeping genes β-actin and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) are known to vary in expression between different experimental setups. 9 Therefore, we explored the use of a sense probe as an internal standard.
MATERIALS AND METHODS

Hepatocyte culture in 96-well collagen-coated plates
Male CBA mice (Bomholtgård A/S, Ry, Denmark), weighing approximately 30 g, or male Sprague-Dawley rats (Taconic, Ty, Denmark), weighing approximately 400 g, were starved for 20 h prior to cell isolation. The livers of halothane-anaesthetized animals were perfused according to the 2-step collagenase perfusion method described by Seglen. 10 The isolation of hepatocytes from mice and rats was approved by local ethical committees of the Swedish National Board for Animal Experiments. Liver perfusion medium and liver digest medium (Life Technologies, Carlsbad, CA), supplemented with 200 U/mL of penicillin and 200 U/mL of streptomycin (Penicillin/Streptomycin, Gibco BRL, Paisley, Scotland), and 0.2 mg/mL Collagenase type IV (Sigma-Aldrich, St. Louis, MO) were used. The softened liver was excised and shaken in Williams' Medium E with Glutamax (Life Technologies) containing 10% fetal bovine serum (FBS; Svanoclone FBS Super, National Veterinary Institute, Uppsala, Sweden) and 200 U/mL of Penicillin/Streptomycin. The cell suspension was filtered through gauze, and the cells were pelleted and resuspended twice in fresh medium. Cell viability was assessed by trypan blue exclusion, and only preparations of >80% viability were accepted. The cells were seeded at a density of 30.000 cells/0.1 mL/well in 96-well collagen-coated microplates (Becton Dickinson, Bedford, MA). Cultures were maintained in a humidified incubator at 37°C in an atmosphere of 5% CO 2 . After 2 h of attachment, the medium was changed to 5% FBS. Next morning, the culture medium was changed to 2.5% FBS and, in the afternoon, to serum-free medium. Approximately 42 h after seeding, the medium was renewed, and the cells were treated with 1:3 dilution series in 9 steps of hGH (Genotropin, Pharmacia AB, Stockholm, Sweden) or the potential GH antagonists BVT-A or BVT-B, both from the Biovitrum compound library. The final concentrations in the cell medium were as follows: 0.2% DMSO (vehicle), 0.8 pM to 5 nM hGH, and 1.5 nM to 10 µM BVT compound. After 6 h of treatment, the medium was aspirated, and 100 µL GuSCN cell lysis buffer (4 M guanidine thiocyanate, 0.1 M EDTA) was added to each well. The plates were sealed, transferred to a -70°C freezer, and stored until assayed. When radioactive probes were used, at the end of stimulation, the cells were fixated for 20 min with 4% Paraformaldehyde (Sigma-Aldrich), and hybridization was performed without delay.
Large-scale hepatocyte culture on Matrigel-coated 10-cm dishes
Matrigel was prepared from Engelbreth-Holm-Swam mouse sarcoma propagated in C57BL/6 female mice as previously described 5 and stored at -20°C. After thawing on ice, 400 µL was evenly inoculated onto 10-cm plastic dishes and allowed to form a gel at room temperature before cell isolation. Hepatocytes were isolated by nonrecirculating collagenase perfusion through the portal vein of isofluran-anaesthetized female Sprague-Dawley rats (Scanbur BK, Stockholm, Sweden), 6 to 8 weeks of age, as previously described. 11 Cell viability was assessed by trypan blue exclusion and averaged 85%. Cells were seeded at a density of 10 × 10 6 / dish in 10 mL Williams' Medium E with Glutamax, supplemented with 17 nM insulin and 100 U/mL of penicillin and 100 U/mL of streptomycin. Cultures were maintained in a humidified incubator at 37°C in an atmosphere containing 5% CO 2 , and the medium was renewed daily. On the 3rd day in culture, cells were treated for 6 h, with 10 µM BVT-A and 2 nM bovine GH (bGH) added 30 min after BVT-A. Bovine GH was used (instead of human GH) to avoid stimulation of the prolactin receptors, which are highly abundant in female rat liver. The cells were washed with ice-cold phosphatebuffered saline (PBS) and harvested in 4 mL SET buffer (1% (w/v) sodium dodecyl sulfate [SDS], 10 mM EDTA, and 20 mM Tris-HCl, pH 7.5). The cell lysates were stored at -20°C for subsequent isolation of total nucleic acids (tNA) and quantification of CYP2C12 and A1BG mRNAs by specific solution hybridization assays.
Preparation of labeled probes
The IGF-1 probe template corresponding to 60 bases of the 3′ end of exon 2 and 179 bases of the 5′ end of exon 3 of mouse IGF-1 cDNA (GenBank no. X04482) was PCR amplified and cloned into the pGEM-4z vector using the EcoRI and HindIII restriction sites. The cDNA sequence of the transcribed IGF-1 fragment (lowercase letters), as well as flanking plasmid sequences (uppercase letters), is given as follows:
SP6→
EcoRI GAAT ACGAATTCGA GCATgcgggg ctgagctggt ggatgctctt Exon 2 ← → Exon 3 cagttcgtgt gtggaccgag gggcttttac ttca | acaagc ccacaggcta tggctccagc attcggaggg cacctcagac aggcattgtg gatgagtgtt gcttccggag ctgtgatctg aggagactgg agatgtactg tgccccactg aagcctacaa aagcagcccg ctctatccgt gcccagcgcc acactgacat gcccaagact cagGCATGCA AGCTTGTCTCCCTATAGTGA GT HindIII ←T7
The IGF-1-pGEM4Z plasmid was purified using the Qiagen EndoFree Plasmid Maxi Kit (Qiagen, Hilden, Germany) according to the manufacturer's instructions. The RNA probes were transcribed using the MaxiScript T7 and SP6 Kit (Ambion, Austin, TX), generating an antisense probe of 279 bases and a sense probe of 264 bases. Radioactively labeled RNA sense and antisense probes were prepared by including [ 33 P]-UTP (Amersham Biosciences, Uppsala, Sweden) in the transcription reaction according to the MaxiScript protocol. Unincorporated nucleotides were removed by gel filtration on NICK columns (Amersham Biosciences), and probe concentration was determined spectrophotometrically. The specific activity of the radioactive probe was determined by scintillation counting. Unlabeled sense and antisense probes were labeled by UV cross-linking with Psoralen-Biotin using the BrightStar Psoralen-Biotin Kit (Ambion) according to the manufacturer's protocol. The degree of labeling was checked by spotting a serial dilution of the probe onto a membrane, UV cross-linking, and detecting probe with streptavidin-alkaline phosphatase as described below.
Hybridization in microplates with radioactive probes
After removal of the fixative, the cells were permeabilized for 20 min with 250 µL/well of 0.25% Triton X-100 in PBS. Hybridization with 20 × 10 6 CPM/mL of [ 33 P]-UTP-labeled probe was done in 50 µL standard hybridization buffer 12 with 50% formamide, 100 mg/mL dextran sulfate, 1× Denhardt's solution, and 0.5 mg/mL tRNA at 42°C overnight. One lane per plate was used for sense probe hybridization as an internal standard. After hybridization, the plates were washed twice on a horizontal shaker with 200 µL/well of 1 × SSC (sodium chloride/sodium citrate 6 ), 30 min, at room temperature. Single-stranded RNA was digested with 100 µL/well of 20 µg/mL RNase A for 30 min. The plates were washed twice with 250 µL/well of 0.25 × SSC and incubated for 45 min at 65°C. After aspiration of wash solution, 50 µL of scintillation liquid was added, the plates were shaken for 10 min, and labeled duplex RNA was counted in a MicroBeta TriLux (Wallac, Turku, Finland).
Filter hybridization assay
Hepatocytes frozen in GuSCN in 96-well microplates were thawed and lysed by pipetting, 80 × 50 µL, using a Quadra 96 pipetting robot (Wallac). Completeness of lysis was confirmed by light microscopy. Using the 96-well plate replicator, 10 µL of lysate from each well was transferred to dry, printed nylon membranes (Wallac), and 2 replica membranes were prepared. The membranes were dried at 70°C for 15 min, and the nucleic acids were immobilized by UV cross-linking (0.120 J, 254 nm). The membranes were prehybridized for 1 h in 10 mL ULTRAhyb buffer (Ambion), followed by hybridization with 1 µL Psoralen-Biotin-labeled probe (~0.1 nM) in the same buffer overnight. The hybridization steps were performed in rolling bottles at 68°C. After hybridization, the membranes were washed 2 × 5 min in 2× SSC containing 0.1% SDS and then 2 × 15 min in 0.1× SSC, 0.1% SDS. The bound biotin-labeled probe was detected with streptavidin-coupled alkaline phosphatase using the BrightStar BioDetect Kit (Ambion), according to the manufacturer's instructions. The membranes were sealed in MicroBeta sample bags (Wallac). Chemiluminescence was measured as counts per second (LCPS), in a Wallac MicroBeta TriLux, 6 h after completion of the detection procedure, the time period found to give maximal signalto-noise ratios (data not shown).
RNase protection assay
Mouse hepatocytes were cultured in 96-well collagen-coated plates as described above. Day 3 in culture, the cells were treated with 1:3 dilution series of hGH at concentrations between 0.8 and 3 nM across rows in the plate. After 6 h of treatment, the cells were lysed in 100 µL Trizol (Life Technologies). Cell lysates from 8 wells were pooled, and total RNA was isolated by phenolchloroform extraction and isopropanol precipitation. The yield of total RNA was determined spectrophotometrically. The [ 33 P]-IGF-1 antisense RNA probe used was prepared as above. A [ 33 P]-GAPDH antisense RNA probe was transcribed from Ambion's mouse GAPDH linearized plasmid template and used as internal standard. The RNase protection assay (RPA) was performed on 5µg hepatocyte RNA using the Ambion RPA III kit (Ambion), and the protected hybrids were separated on urea-PAGE according to the manufacturer's instructions. Protected hybrids were visualized by phosphoimaging.
Northern blot
Rat hepatocytes were prepared as described earlier and seeded at a density of 3 × 10 6 cells/well in 6-well collagen-coated plates (Becton Dickinson). The cultures were maintained in 3 mL Williams' Medium E with Glutamax, with reduction of serum as described above. Day 3 in culture, the cells were treated for 6 h with 1 µM BVT-A or BVT-B in the presence or absence of 3 nM hGH; hGH was added 30 min after the addition of BVT compound. The cells were lysed in 1 mL of 4 M guanidine thiocyanate, 25 mM sodium citrate, 0.5% sarcosyl, and 0.1 M 2-mercaptoethanol, and total RNA was isolated. Then, 10 µg RNA was separated in formaldehyde-containing 1% agarose gel. The RNA was blotted onto Gene Screen Plus Hybridization transfer membranes (NEN Life Science Products, Boston, MA), washed in 2 × SSC, and covalently linked to the membrane by UV irradiation. The membranes were prehybridized at 68°C for 30 min in ULTRAhyb buffer and hybridized overnight in the same buffer with 4 µL (~0.4 nM) Psoralen-Biotin-labeled antisense RNA probes corresponding to β-actin, or GAPDH. The β-actin and GAPDH probes were transcribed from Ambion's mouse linearized plasmid templates. The membranes were washed 2 × 5 min in 2× SSC, 0.1% SDS, and 2 × 15 min in 0.1× SSC, 0.1% SDS. The bound biotin-labeled probe was detected using the BrightStar BioDetect Kit according to the manufacturer's instructions. The bands were visualized on x-ray film.
Cell viability assay
Rat hepatocytes were cultured in 96-well collagen-coated plates and treated with a dilution series of BVT-A and BVT-B for 20 h as described above. The CellTiter 96 Aqueous Non-Radioactive Cell Proliferation Assay (Promega, Madison, WI) was used to detect metabolically active cells. The assay reagent mix was prepared according to the manufacturer's instructions, and 20 µL was added to each well. In metabolically active cells, the assay reagent is reduced by dehydrogenases to a product detectable spectrophotometrically at 490 nm, with the signal being directly proportional to the number of living cells. The cells were incubated with assay reagent for 1 h at 37°C in a humidified 5% CO 2 atmosphere, and the absorbance at 490 nm was measured using a Victor V plate reader (Wallac).
Solution hybridization
Total nucleic acids were prepared by digestion of the cell lysate with proteinase K, followed by phenol-chloroform extraction as previously described. 5 The concentration of tNA in the samples was determined spectrophotometrically, and the DNA concentration was quantified using a fluorometric assay. 13 The levels of CYP2C12 and A1BG mRNA were analyzed using specific [ 35 S]-UTP-labeled cRNA probes. The probes and assay conditions for CYP2C12 and A1BG have been described previously. 14, 15 Quantitation was achieved by comparison with standard curves obtained from hybridization to liver tNA. The liver tNA standards were calibrated to known amounts of in vitro synthesized mRNA. Samples were analyzed in triplicate, and the results were expressed as attomoles per µg DNA. Data shown are the mean ± standard deviation from 3 independent dishes.
RESULTS AND DISCUSSION
The most commonly used technique for mRNA quantification today is probably real-time PCR (RT-PCR). This is a multistep process that requires RNA purification prior to the analysis. The processes can be automated, as described by Ullmann and others. 7 However, it requires expensive reagents and special equipment (combined thermal cycler-detector) and, due to the RNA purification step, a relatively large amount of starting material. Another established high-throughput method for RNA quantification is the branched-chain DNA (bDNA) technology. 16 The b-DNA method is based on signal amplification in contrast to the target amplification employed in RT-PCR. The analysis can be performed directly on the cells, without RNA purification. However, the b-DNA method is based on the hybridization of a number of target-specific probes for each gene, making it very expensive if a large number of different genes are to be tested. Thus, for screening purposes, the direct hybridization assay we describe using crude cellular lysates, as well as reasonably priced reagents and equipment, is advantageous.
Determination of amount of cellular material required for filter hybridization assay
Initially, we investigated if the amount of hepatocyte RNA from 96-well plate cultures was sufficient to quantify IGF-1 mRNA. Cells from 8 wells were pooled, RNA was extracted, and 5 µg was hybridized to IGF-1 and GAPDH RNA probes in RPA. As shown in Figure 1 , this amount of RNA readily allowed detection of both IGF-1 and GAPDH mRNA using RPA. Considering the inevitable loss of RNA during extraction procedures and the subsequent RPA, the amount of IGF-1 mRNA per well would not be a limiting factor in establishing a filter hybridization assay on crude cellular lysates in the 96-well format.
Evaluation of probe type and labeling for use in filter hybridization assay
When comparing methods of probe labeling, the sample detection limit will depend on not only the amount of incorporated label but also the setup of the assay and the instrument used to detect the signal. From an assay point of view, they differ with regard to signal-to-noise ratios and long-term stability. We analyzed different nonradioactive labeling alternatives and the use of either DNA or RNA probes. Transcriptional labeling with fluorescein or biotin has disadvantages because the bulkiness of the incorporated molecules could impair hybridization, and initial experiments yielded probes with a too low detection limit (data not shown). Furthermore, fluorescein is very light sensitive, thus shortening the lifetime of the probe, and biotin interferes with spectrophotometric FIG. 1. Insulin-like growth factor-1 (IGF-1) and glyceraldehyde-3phosphate dehydrogenase (GAPDH) mRNA in primary mouse hepatocytes detected by RNase protection assay (RPA). Cells were treated with different doses of human growth hormone (hGH) for 6 h, and total RNA was extracted from pooled cells from 8 wells of a 96-well plate. Then, 5 µg RNA was subjected to RPA, as described in Materials and Methods.
quantification. Long wave-length-emitting, photo-stable fluorophores such as the Alexa Fluor and Cy dyes can be analyzed for degree of labeling by measuring absorbance and fluorescence. 17 However, the general use of fluorophores in filter hybridization assays is limited because of the high background signal from the filter due to light scattering and auto fluorescence, resulting in low sensitivity.
Labeling with intercalating Psoralen-Biotin, incorporated after transcription, does not compromise hybridization 18 (Ambion's Technical Bulletin #175). BrightStar Psoralen-Biotin consists of a tricyclic, planar, intercalating Psoralen moiety conjugated to biotin. When irradiated with long-wave UV light, the Psoralens become covalently attached to nucleic acids. Biotinylated probes can be detected enzymatically by the highly specific ligand streptavidin conjugated to alkaline phosphatase. The magnifying nature of the enzyme-substrate reaction provides the possibility for high sensitivity of the detection. Moreover, the detection limit of luminescence counts is not reduced by quenching, whereas this might be a limiting factor for fluorescence detection. 19 When comparing DNA and RNA probes labeled with Psoralen-Biotin, we found that the DNA probe generated a higher signal than the RNA probe when serial dilutions of probe were spotted on nylon membranes (Fig. 2 ). This can be explained by Psoralen-Biotin preferably binding to thymidines present in the DNA and, to a lesser extent, to uridines in the RNA. Also, the DNA probe will probably be more tightly bound to the membrane because thymidines are cross-linked at a higher extent than the other nucleotides. 12 However, when hybridized to cell lysates in the 96-well format as described above, the signal from the DNA probe, even though the hybridization was performed at a lower temperature, was not significantly higher than the RNA probe signal (data not shown). This is most likely due to the DNA-RNA hybrid being less stable than the RNA-RNA duplex. It can, however, not be excluded that some probe cross-linking may have occurred during labeling, although the DNA probe was denatured prior to irradiation.
One important advantage of using RNA probes is the possibility to use sense probe hybridization as an internal standard. It is known that the expression of commonly used internal standards, such as the housekeeping genes GAPDH and β-actin, can vary widely with different experimental conditions, 9 and it is conceivable that stimulation with growth-promoting substances such as GH would affect the expression of these genes. Such unwanted transcriptional events would lead to both false-positive and falsenegative results. In drug discovery, false-positive results can be eliminated by using a screening funnel with orthogonal assays, whereas false-negative results might lead to loss of information regarding active compounds. When using the same conditions for hybridization and detection of the sense and antisense probes on the replica filters, the sense hybridization signal can be deducted from the antisense signal. The resulting signal thus represents the specific mRNA corrected for variations in the amount of starting material, background, unspecific binding, and specific hybridization to DNA in the lysate.
The general utility of the sense and antisense approach will depend on the ability to make cloning constructs that give probe pairs of similar lengths when transcribed from opposite directions. If such a probe pair is transcribed and labeled in parallel, the result will be a similar degree of labeling. We used the restriction sites most adjacent to the transcription start sites in the pGEM4Z vector for cloning of the IGF-1 cDNA fragment to generate probes of equal length. The generated antisense and sense probes were 279 and 264 bases, respectively. The probes cannot be quantitated by absorbance measurements at 260 nm after Psoralen-Biotin labeling because Psoralen absorbs at this wavelength. However, spectrophotometric quantitation done before labeling is adequate because the loss of labeled nucleic acid in the buthanol extraction is negligible. 12 Probe quality and degree of labeling have to be determined empirically before use in hybridization assays. By analyzing the nucleic acid concentration spectrophotometrically and confirming the probe integrity by gel electrophoresis, sufficient probe quality is ensured. However, prior to use, the activity of the labeled probe pairs has to be evaluated by spotting serial dilutions of the probes on filters. As shown in Figure 3 , the sense and antisense IGF-1 RNA probes were approximately labeled equally.
IGF-1 mRNA levels in GH-treated hepatocytes analyzed by filter hybridization assay in 96-well format
The time course of the GH-mediated effect on IGF-1 is dependent on de novo synthesis of transcription factors, which results in a lag time between stimulation and maximal response. 20 Using hybridization with radioactive IGF-1 probes, we analyzed the response to GH after 6, 12, and 24 h of incubation of cells in the 96well format. The peak induction after the 6-and 12-h incubation occurred at 2 nM GH, whereas maximal induction at 24 h was ob-tained at 20 nM GH. Because the stimulated IGF-I levels compared to basal level were not improved by prolonged incubation (Fig. 4) , we choose to stimulate the cells for 6 h to shorten assay time.
Cell lysates from mouse and rat hepatocytes cultured in 96-well plates were subjected to hybridization using antisense and sense IGF-1 RNA probes. As shown in Figure 5 , the induction of mouse IGF-1 mRNA was about 5-fold when the background hybridization signal obtained by the sense probe was deducted from the antisense hybridization signal. Similar results were obtained using cultured rat hepatocytes (Fig. 6 ). These results are in line with the GH induction of IGF-1 mRNA seen in vivo and in vitro in other studies where isolated RNA or total nucleic acid samples have been used for detection of the transcript. 5 The dose-response curve of GH stimulation in cellular assays is bell shaped because a 2:1 receptor-ligand relationship is needed to activate downstream signaling events. Excess GH will cause each receptor monomer to be occupied by ligand, and no signal transduction leading to IGF-1 expression will be generated. 21 In the mouse hepatocytes, a significant amount of IGF-1 mRNA was expressed in untreated control cells ( Fig. 5 ), which indicates that the culture system, including the 96-well format, constitutes an adequate model of the hepatocyte in vivo. It has been shown that about 20% of the total liver production of IGF-1 is independent of GH. 22 In Figure 6 , the basal IGF-1 mRNA levels were less than in Figure 5 , reflecting interassay variations.
The possibility to use the same probes to study the effect of substances in different species is advantageous in drug discovery. We used the same probes for the quantification of both mouse and rat IGF-1 mRNA, although sequence comparison showed 2 mismatches between the mouse and rat IGF-1 genes in the probe area. Due to the substantial length of the probes (279 and 264 nucleotides), these mismatches were tolerated, although a relatively high hybridization stringency was employed. This is in contrast to methods such as real-time PCR and bDNA assays, which require perfectly matched probes. 7, 16 
Effect of GH antagonists on IGF-1 mRNA levels in hepatocytes, analyzed by filter hybridization assay in 96-well format
A set of low molecular weight compounds had previously been selected by binding to the GH receptor (i.e., they were considered to be potential GH antagonists). The ability of these compounds to cause inhibition of GH-stimulated IGF-1 mRNA expression was analyzed using the filter hybridization assay. A dose-dependent decrease of GH-induced IGF-1 mRNA was obtained with the compounds BVT-A and BVT-B (Fig. 7) , both from the Biovitrum screening library. The y-axis shows the antisense probe signal minus the sense probe signal, and a 1-site sigmoid dose response curve was fitted to the data points using Excel-fit. This equation gave an IC 50 value of 18 nM for BVT-A and 14.5 nM for BVT-B (Fig. 7) .
Further validation of the GH antagonistic properties of the compounds
To exclude potential cell toxicity of the GH antagonistic compounds, a spectrophotometric cell viability assay was employed.
We did not detect any change in cell viability following treatment with compounds for 20 h (data not shown). To determine if the IGF-1 mRNA down-regulation was the result of overall changes in transcriptional regulation, the mRNA levels of the housekeeping genes β-actin and GAPDH were determined by Northern blot. BVT-A did not change the expression of these genes, whereas BVT-B in fact induced β-actin expression and also slightly induced GAPDH (Fig. 8) , indicating a potential mitogenic effect. These results indicate a specific antagonistic effect of BVT-A on IGF-1 mRNA expression and also emphasize the importance of including appropriate controls when quantifying gene expression.
Effects of BVT-A on GH-stimulated CYP2C12 and A1BG gene expression
To further confirm the GH-antagonistic properties of BVT-A, additional hepatic GH target genes were analyzed. The CYP 2C12 and A1BG genes are both induced by GH in the female rat liver. 23 Human GH is known to bind and activate the rat prolactin receptor; therefore, we used bovine GH in this experiment. We investigated the effect of BVT-A on the GH-induced expression of these markers in primary rat hepatocytes. Treatment with 10 µM of BVT-A reduced the GH-induced level of CYP 2C12 mRNA by 35% and A1BG mRNA by 24% (Fig. 9A,B) . Thus, the GH-antagonistic property of BVT-A, as demonstrated for IGF-1 mRNA expression using the minimally laborious filter hybridization technique in the 96-well format, could be confirmed.
CONCLUSION
We have established an assay by which gene expression in primary hepatocytes cultured in the 96-well format can be analyzed by the hybridization of nonradioactive sense and antisense probes to crude cell lysates spotted onto nylon filters. The assay was employed for screening of potential GH antagonists, with the readout being IGF-1 mRNA expression. Using the method, 2 GH antagonists were identified, and their specificity was confirmed by excluding toxicity and general inhibition of transcriptional regulation. The validity of the assay and the GH-antagonistic effect of BVT-A were confirmed by using large-scale hepatocyte cultures and other hybridization methods in studies on hepatic GH target genes other than IGF-1. Furthermore, in vivo testing of BVT-A in male Sprague-Dawley rats results in decreased plasma levels of IGF-1 and decreased growth. 24 The developed hybridization assay will be a valuable tool in further screenings of compounds with GH-antagonistic or agonistic properties. With other probe sets, the assay has a more general application in the screening of pharmacologically active compounds acting on the liver. Journal of Biomolecular Screening 10 ( The hepatocytes were exposed to bGH for 6 h and BVT-A for 6.5 h. The mRNA levels were assessed by specific solution hybridization assays. Data, expressed as attomoles mRNA per microgram DNA, are the mean ± standard deviation from the analysis of 3 dishes.
